Atlas Trials

Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab

Clinical trial NCT00941135 · TERMINATED

Trial details

NCT number
NCT00941135
Sponsor
Fundacion Miguel Servet
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Laryngeal Neoplasms
Start date
2009-05-01
Primary completion
2013-05-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.